Read Larry Connors' blog – Short Term Trading Strategies
The new website is intended to serve as a resource for bariatric surgeons, primary care physicians, endocrinologists, nurses and members of the allied health community. It provides access to hundreds of articles and research papers that will help health professionals address the needs of bariatric patients - from initial interest through post-operative care. Innovative products and technologies are also featured. In addition, surgeons can sign up for the Surgeon Locator directory, which enables referring physicians to connect potential patients with qualified surgeons in their area.
Unique functions of BariatricsPro.com include: podcasts of informational presentations, clinical resources, new products page, practice management tools geared towards business development executives and a bariatric events and activities calendar.
"BariatricsPro.com is an important tool for providing medical professionals with information that will help them determine which of their patients are viable candidates for surgery, as well as answer questions about the treatment," said Michael Tarnoff, M.D., FACS, Chief Medical Officer & VP Medical Affairs, Surgical Devices, Covidien. "Covidien has a steadfast commitment to ongoing research, education and support that will continue to unlock new breakthroughs and opportunities in bariatric surgery, including the eradication of Type 2 Diabetes. BariatricsPro.com will help us share this information with a worldwide audience."
Given the growing demand for bariatric surgery and the continuing rapid advances in related technology, physicians and other healthcare professionals need access to the latest, most up-to-date information to share with their patients.
Currently, more than two-thirds of U.S. adults are considered overweight or obese; more than 25 percent of the adult population struggles with obesity.(1) In 2008, an estimated 220,000 Americans with morbid obesity elected to undergo bariatric surgery,(2) compared with only 13,365 in 1998,(3) a 10-year period during which major advances in surgical techniques and procedures were made. Studies have shown that gastric bypass surgery resolves Type 2 Diabetes, which affects millions of Americans, in approximately 77 percent(4) of morbidly obese patients.
"This site will be of interest to any family doctor who has questions about bariatric surgery, how to select patients, what the patient will go through, what happens after surgery and how to deal with delayed problems including new exercise regimes and nutritional modifications," said Rick Ricer, M.D. "This is a 'one-stop shopping' site."
Also launched this week was Covidien's Our Resolution movement, a collaboration of healthcare experts, nonprofits and health agencies who share the goal of resolving Type 2 Diabetes. The Our Resolution movement will further educate the medical community about bariatric surgery's role in resolving this disease through in-person presentations throughout the country.
In 2008, Covidien launched bariatrics4diabetes.com, a companion site for prospective patients interested in in-depth information on bariatric surgery and the resolution of Type 2 Diabetes.
1. Mayo Clinic, www.mayoclinic.com/health/obesity/DS00314
2. American Society for Bariatric & Metabolic Surgery, http://www.bio-medicine.org/medicine-news-1/Chicago-area-ASBS-Bariatric
3. Santry HP, Gillen DL, Lauderdale DS (2005) Trends in bariatric surgical procedures. JAMA 294(15):1909-1917
4. Buchwald, H. et al, Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine. Vol. 22, No. 3, March 2009. pg 248-256e
About Covidien
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit covidien.com to learn more about our business.
SOURCE: Covidien
Covidien Diana Sousa, 203-492-7610 Vice President Communications Surgical Devices diana.sousa@covidien.com or Bruce Farmer, 508-452-4372 Vice President Public Relations bruce.farmer@covidien.com or Coleman Lannum, CFA, 508-452-4343 Vice President Investor Relations cole.lannum@covidien.com or Brian Nameth, 508-452-4363 Director Investor Relations brian.nameth@covidien.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
